H19 and cancer: Moreover, monocyte-derived exosomes may transfer oncogenic non-coding RNAs (e.g., miR-21, lncRNA H19) to residual cancer cells, maintaining stemness (38)—a plausible mechanism for the dismal long-term survival in high-risk patients (5-year OS: 19.1%).